Meritxell Salvadó

Meritxell Salvadó

Auto-generated profile, based on publicly available information

Meritxell Salvadó

Department of Internal Medicine, Hospital Sant Joan de Déu de Martorell, Barcelona, Spain; Department of Internal Medicine. Hospital de Mollet, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2010 in Thorax
Verified
Journal Article
Open access
PDF file
Pere AlmagroPere Almagro
Pere Almagro
MSM Salvado
M Salvado
CGCarolina Garcia-Vidal
Carolina Garcia-Vidal
MRM Rodriguez-Carballeira
M Rodriguez-Carballeira
MDM Delgado
M Delgado
JSJoan B Soriano
Joan B Soriano
Background Evidence-based international guidelines on chronic obstructive pulmonary disease (COPD), and their corresponding recommendations, were established to improve individual COPD prognosis, and ultimately to improve survival. The aim of this study was to determine whether the long-term mortality after discharge from a COPD hospitalisation has improved recently, and the effect of co-morbidity treatment in improving COPD prognosis. Methods In a prospective cohort study design of two cohorts 7 years apart, patients discharged from the same university hospital after a COPD exacerbation were followed-up, and their outcomes compared. Demographic and clinical variables, as well as lung function, were collected with the same protocol by the same investigators. Comprehensive assessments of co-morbidities and treatments were undertaken. Kaplan–Meier survival curves were estimated, and outcomes were compared by means of Cox regression methods. Results Overall, 135 participants in the 1996–7 cohort and 181 participants in the 2003–4 cohort were studied. Both cohorts were comparable in their baseline demographic and clinical variables, and median follow-up was 439 days. The 3-year mortality was lower in the 2003–4 cohort (38.7%) than in the 1996–7 cohort (47.4%) (p=0.017), and the RR of death after adjustment for gender, age, body mass index, co-morbidities, lung function and mMRC (modified Medical Research Council scale) dyspnoea was 0.66 (95% CI 0.45 to 0.97). Long-term survival improved in the second cohort for patients with COPD with heart failure or cancer (p<0.001). Conclusions A recent trend towards better prognosis of patients with COPD after hospital discharge is described and is likely to be associated with better management and treatment of COPD and co-morbidities.

4 January 2010 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
MSMeritxell Salvadó
Meritxell Salvadó
CGCarolina Garcia-Vidal
Carolina Garcia-Vidal
PVPilar Vázquez
Pilar Vázquez
MRMontserrat Riera
Montserrat Riera
MRMónica Rodríguez‐Carballeira
Mónica Rodríguez‐Carballeira
JGJavier Garau
Javier Garau

21 October 2022 in European Journal of Internal Medicine
Verified
Journal Article
Closed access
HMHelena Monzón
Helena Monzón
LGLaura Gisbert
Laura Gisbert
MSMeritxell Salvadó
Meritxell Salvadó
MPMiquel Puyol
Miquel Puyol
MXMariona Xercavins
Mariona Xercavins
ECEsther Calbo
Esther Calbo

31 January 2009 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
MSMeritxell Salvadó
Meritxell Salvadó
BBBienvenido Barreiro
Bienvenido Barreiro
CGClarisa González
Clarisa González